Detalles de la búsqueda
1.
A new way of identifying viral pathogens reactivating in cellular therapy products.
Immunol Cell Biol
; 102(3): 153-155, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38238927
2.
Investigation of product-derived lymphoma following infusion of piggyBac-modified CD19 chimeric antigen receptor T cells.
Blood
; 138(16): 1391-1405, 2021 10 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-33974080
3.
Combining CD34+ stem cell selection with prophylactic pathogen and leukemia directed T-cell immunotherapy to simultaneously reduce graft versus host disease, infection, and leukemia recurrence after allogeneic stem cell transplant.
Am J Hematol
; 98(1): 159-165, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35560045
4.
Long-term outcomes of corticosteroid graft versus host disease prophylaxis in peripheral blood allogeneic haemopoietic stem cell transplant: a comparative cohort analysis.
Intern Med J
; 53(11): 1979-1986, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36878730
5.
Unrelated Donor Transplant Recipients Given Thymoglobuline Have Superior GRFS When Compared to Matched Related Donor Recipients Undergoing Transplantation without ATG.
Biol Blood Marrow Transplant
; 26(10): 1868-1875, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32640314
6.
Pre- and post-bone marrow harvest anaemia is associated with lower CD34+ stem cell collection, high harvest volume and female gender.
Intern Med J
; 50(3): 299-306, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31276271
7.
Chimeric Antigen Receptors for the Tumour Microenvironment.
Adv Exp Med Biol
; 1263: 117-143, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32588326
8.
PiggyBac-Engineered T Cells Expressing CD19-Specific CARs that Lack IgG1 Fc Spacers Have Potent Activity against B-ALL Xenografts.
Mol Ther
; 26(8): 1883-1895, 2018 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29861327
9.
Adjuvant Peptide Pulsed Dendritic Cell Vaccination in Addition to T Cell Adoptive Immunotherapy for Cytomegalovirus Infection in Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
Biol Blood Marrow Transplant
; 24(1): 71-77, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28864137
10.
Establishment and Operation of a Third-Party Virus-Specific T Cell Bank within an Allogeneic Stem Cell Transplant Program.
Biol Blood Marrow Transplant
; 24(12): 2433-2442, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30172015
11.
Manipulating the tumor microenvironment by adoptive cell transfer of CAR T-cells.
Mamm Genome
; 29(11-12): 739-756, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29987406
12.
Development of CAR T-cell lymphoma in 2 of 10 patients effectively treated with piggyBac-modified CD19 CAR T cells.
Blood
; 138(16): 1504-1509, 2021 10 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34010392
13.
Herpes simplex virus type 1 (HSV-1) specific T-cell generation from HLA-A1- and HLA-A2-positive donors for adoptive immunotherapy.
Cytotherapy
; 19(1): 107-118, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27793552
14.
Influence of Stem Cell Source on Outcomes of Allogeneic Reduced-Intensity Conditioning Therapy Transplants Using Haploidentical Related Donors.
Biol Blood Marrow Transplant
; 21(9): 1641-5, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26079442
15.
Single-Agent High-Dose Cyclophosphamide for Graft-versus-Host Disease Prophylaxis in Human Leukocyte Antigen-Matched Reduced-Intensity Peripheral Blood Stem Cell Transplantation Results in an Unacceptably High Rate of Severe Acute Graft-versus-Host Disease.
Biol Blood Marrow Transplant
; 21(5): 941-4, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25636379
16.
Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation.
Blood
; 121(18): 3745-58, 2013 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-23435462
17.
Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study.
Blood
; 122(17): 2965-73, 2013 Oct 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-24030379
18.
Low-cost generation of Good Manufacturing Practice-grade CD19-specific chimeric antigen receptor-expressing T cells using piggyBac gene transfer and patient-derived materials.
Cytotherapy
; 17(9): 1251-67, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26212611
19.
Addition of varicella zoster virus-specific T cells to cytomegalovirus, Epstein-Barr virus and adenovirus tri-specific T cells as adoptive immunotherapy in patients undergoing allogeneic hematopoietic stem cell transplantation.
Cytotherapy
; 17(10): 1406-20, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26349000
20.
Cytomegalovirus-specific cytotoxic T lymphocytes can be efficiently expanded from granulocyte colony-stimulating factor-mobilized hemopoietic progenitor cell products ex vivo and safely transferred to stem cell transplantation recipients to facilitate immune reconstitution.
Biol Blood Marrow Transplant
; 19(5): 725-34, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23380344